Kei Sonehara

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Topics

Urinary Tract Infection

Prognostic Factors

Neoadjuvant Chemotherapy

Cross Sectional

Top Venues

Thoracic cancer

Cancer medicine

Respirology case reports

Cancer management and research

This page only lists publications with an associated author ORCID identifier.

Publications

Ryota Ozawa, Kei Sonehara, Tsutomu Hachiya, Shuhei Nozawa, Toshihiko Agatsuma, Hiroshi Yamamoto, Akane Kato, Akemi Matsuo, Taro Hirabayashi, Taisuke Araki, Masamichi Komatsu, Kazunari Tateishi, Masayuki Hanaoka
Evaluation of the association between predictive factors and the development of immune-related adverse events and prognostic factors for chemoimmunotherapy in patients with non-small cell lung cancer: A multicenter retrospective study. Cancer medicine 13 (15) (2024)
Ryota Ozawa, Kei Sonehara, Tsutomu Hachiya, Shuhei Nozawa, Toshihiko Agatsuma, Hiroshi Yamamoto, Akane Kato, Akemi Matsuo, Taro Hirabayashi, Taisuke Araki, Masamichi Komatsu, Kazunari Tateishi, Masayuki Hanaoka
Evaluation of the association between predictive factors and the development of immune-related adverse events and prognostic factors for chemoimmunotherapy in patients with non-small cell lung cancer: A multicenter retrospective study. Cancer medicine 13 (15) (2024)
Ryota Ozawa, Kei Sonehara, Tsutomu Hachiya, Shuhei Nozawa, Toshihiko Agatsuma, Hiroshi Yamamoto, Akane Kato, Akemi Matsuo, Taro Hirabayashi, Taisuke Araki, Masamichi Komatsu, Kazunari Tateishi, Masayuki Hanaoka
Evaluation of the association between predictive factors and the development of immune-related adverse events and prognostic factors for chemoimmunotherapy in patients with non-small cell lung cancer: A multicenter retrospective study. Cancer medicine 13 (15) (2024)
Kei Sonehara, Ryota Ozawa, Mineyuki Hama, Shuhei Nozawa, Toshihiko Agatsuma, Kenichi Nishie, Akane Kato, Akemi Matsuo, Taisuke Araki, Masamichi Komatsu, Kazunari Tateishi, Masayuki Hanaoka
C-PLAN index as a prognostic factor for patients with previously untreated advanced non-small cell lung cancer who received combination immunotherapy: A multicenter retrospective study. Thoracic cancer 14 (6) (2023)
Kei Sonehara, Ryota Ozawa, Mineyuki Hama, Shuhei Nozawa, Toshihiko Agatsuma, Kenichi Nishie, Akane Kato, Akemi Matsuo, Taisuke Araki, Masamichi Komatsu, Kazunari Tateishi, Masayuki Hanaoka
C-PLAN index as a prognostic factor for patients with previously untreated advanced non-small cell lung cancer who received combination immunotherapy: A multicenter retrospective study. Thoracic cancer 14 (6) (2023)
Kei Sonehara, Ryota Ozawa, Mineyuki Hama, Shuhei Nozawa, Toshihiko Agatsuma, Kenichi Nishie, Akane Kato, Akemi Matsuo, Taisuke Araki, Masamichi Komatsu, Kazunari Tateishi, Masayuki Hanaoka
C-PLAN index as a prognostic factor for patients with previously untreated advanced non-small cell lung cancer who received combination immunotherapy: A multicenter retrospective study. Thoracic cancer (2023)
Kei Sonehara, Ryota Ozawa, Mineyuki Hama, Shuhei Nozawa, Toshihiko Agatsuma, Kenichi Nishie, Akane Kato, Akemi Matsuo, Taisuke Araki, Masamichi Komatsu, Kazunari Tateishi, Masayuki Hanaoka
C-PLAN index as a prognostic factor for patients with previously untreated advanced non-small cell lung cancer who received combination immunotherapy: A multicenter retrospective study. Thoracic cancer 14 (6) (2023)
Taisuke Araki, Kazunari Tateishi, Masamichi Komatsu, Kei Sonehara, Shintaro Kanda, Masayuki Hanaoka, Tomonobu Koizumi
Association of lung immune prognostic index with survival outcome in advanced thymic carcinoma patients treated with palliative intent chemotherapy. Thoracic cancer 13 (7) (2022)
Kei Sonehara, Kazunari Tateishi, Taisuke Araki, Masamichi Komatsu, Jumpei Akahane, Hiroshi Yamamoto, Masayuki Hanaoka
Predictive Factors Correlated with the Development of Immune-Related Adverse Events in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Cancer management and research 14 (2022)
Taisuke Araki, Kazunari Tateishi, Masamichi Komatsu, Kei Sonehara, Satoshi Wasamoto, Shigeru Koyama, Fumiaki Yoshiike, Mineyuki Hama, Kenichi Nishie, Daichi Kondo, Toshihiko Agatsuma, Akane Kato, Munetake Takata, Shintaro Kanda, Masayuki Hanaoka, Tomonobu Koizumi
Predictive value of post-treatment C-reactive protein-to-albumin ratio in locally advanced non-small cell lung cancer patients receiving durvalumab after chemoradiotherapy. Thoracic cancer 13 (14) (2022)
Sachie Koike, Kimihiro Shimizu, Shogo Ide, Shuji Mishima, Shunichiro Matsuoka, Tetsu Takeda, Kentaro Miura, Takashi Eguchi, Kazutoshi Hamanaka, Taisuke Araki, Kei Sonehara, Keisuke Todoroki, Fumihito Ichinohe, Satoshi Kawakami, Masayoshi Koinuma
Is using a consolidation tumor ratio 0.5 as criterion feasible in daily practice? Evaluation of interobserver measurement variability of consolidation tumor ratio of lung cancer less than 3 cm in size. Thoracic cancer 13 (21) (2022)
Kei Sonehara, Taisuke Araki, Masayuki Hanaoka
Rothia aeria pneumonia in an immunocompetent patient: A novel case study. Respirology case reports 9 (10) (2021)
Taisuke Araki, Yoshiaki Kitaguchi, Yusuke Suzuki, Masamichi Komatsu, Kei Sonehara, Yosuke Wada, Kazunari Tateishi, Masayuki Hanaoka
Prognostic implication of erector spinae muscles in non-small-cell lung cancer patients treated with immuno-oncology combinatorial chemotherapy. Thoracic cancer 12 (21) (2021)
Taisuke Araki, Kazunari Tateishi, Kei Sonehara, Shuko Hirota, Masamichi Komatsu, Manabu Yamamoto, Shintaro Kanda, Hiroshi Kuraishi, Masayuki Hanaoka, Tomonobu Koizumi
Clinical utility of the C-reactive protein:albumin ratio in non-small cell lung cancer patients treated with nivolumab. Thoracic cancer 12 (5) (2021)
Kei Sonehara, Kazunari Tateishi, Taisuke Araki, Masamichi Komatsu, Hiroshi Yamamoto, Masayuki Hanaoka
Prognostic value of the geriatric nutritional risk index among patients with previously treated advanced non-small cell lung cancer who subsequently underwent immunotherapy. Thoracic cancer 12 (9) (2021)
Kei Sonehara, Kazunari Tateishi, Masamichi Komatsu, Hiroshi Yamamoto, Masayuki Hanaoka
Lung immune prognostic index as a prognostic factor in patients with small cell lung cancer. Thoracic cancer 11 (6) (2020)
Kei Sonehara, Kazunari Tateishi, Toshirou Fukushima, Masamichi Komatsu, Hiroshi Yamamoto, Tomonobu Koizumi, Masayuki Hanaoka
The efficacy of amrubicin third-line chemotherapy in patients with relapsed extensive-disease small-cell lung cancer: A retrospective and historical study in a single institute. Thoracic cancer 10 (9) (2019)
Kei Sonehara, Toshitaka Shomura, Masanori Yasuo, Atsuhito Ushiki, Hiroshi Yamamoto, Masayuki Hanaoka
Successful ventilator weaning following vascular bypass in patient with vascular tracheobronchial compression. Respirology case reports 6 (5) (2018)